International validation of novel pyrogen tests based on human monocytoid cells

Journal of Immunological Methods

Volumn 298, Issue 1-2, 2005, Pages 161-173

  Hoffmann, Sebastian ^a,h   Peterbauer, Anja ^e,j   Schindler, Stefanie ^a   Fennrich, Stefan ^a   Poole, Stephen ^b   Mistry, Yogesh ^b   Montag Lessing, Thomas ^c   Spreitzer, Ingo ^c   Löschner, Bettina ^c   Van Aalderen, Mirjam ^d   Bos, Rogier ^d   Gommer, Martin ^d   Nibbeling, Ria ^d   Werner Felmayer, Gabriele ^e   Loitzl, Petra ^e   Jungi, Thomas ^f   Brcic, Marija ^f   Brügger, Peter ^g   Frey, Esther ^g   Bowe, Gerard ^h   Casado, Juan ^h   Coecke, Sandra ^h   De Lange, Jan ^h   Mogster, Bente ⁱ   Næss, Lisbeth M ⁱ   Aaberge, Ingeborg S ⁱ   Wendel, Albrecht ^a   Hartung, Thomas ^a,h   more..

^a UNIVERSITY OF KONSTANZ   (Germany)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c PAUL EHRLICH INSTITUT   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e Institute of Biochemistry   (Austria)

^f UNIVERSITY OF BERN   (Switzerland)

^g NOVARTIS PHARMA AG   (Switzerland)

^h JOINT RESEARCH CENTRE   (Italy)

ⁱ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^j LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

more..

Author keywords

Alternatives to animals; Cell culture; Cytokines; Monocytes; Pyrogens; Validation study

Indexed keywords

AMPICILLIN; DIMETINDENE; ENDOTOXIN; MCP; METOCLOPRAMIDE; METOPROLOL TARTRATE; OXYTOCIN; RANITIDINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTAMINATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY; MONOCYTE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; TIME; VALIDATION PROCESS;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; POSIBACTERIA;

EID: 20244375715     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.01.010     Document Type: Article

References (39)

1. M. Balls, B. Blaauboer, D. Brusick, J. Frazier, D. Lamb, M. Pemberton, C. Reinhardt, M. Roberfroid, H. Rosenkranz, B. Schmid, H. Spielmann, A.L. Stammati, and E. Walum Report and recommendations of the CAAT/ERGATT workshop on validation of toxicity test procedures Altern. Lab. Anim. 18 1990 303
2. M. Balls, B. Blaauboer, J.H. Fentem, L. Bruner, R.D. Combes, B. Ekwall, R.J. Fielder, A. Guillouzo, R.W. Lewis, D.P. Lovell, G. Repetto, D. Sladowski, H. Spielmann, and F. Zucco Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5 Altern. Lab. Anim. 23 1995 129
3. B. Beutler, and E.T. Rietschel Innate immune sensing and its roots: the story of endotoxin Nat. Rev., Immunol. 3 2003 169
4. C.J. Clopper, and E.S. Pearson The use of confidence or fiducial limits illustrated in the case of the binomial Biometrika 26 1934 404
5. Council of Europe Biological tests, 2.6.14. Bacterial endotoxins European pharmacopoeia 2001 Council of Europe Strasbourg 140
6. Council of Europe Biological tests, 2.6.8. Pyrogens European pharmacopoeia 2001 Council of Europe Strasbourg 131
7. C.A. Dinarello Cytokines as endogenous pyrogens J. Infect. Dis. 179 Suppl 2 1999 294
8. C.A. Dinarello, J.V. O'Connor, G. LoPreste, and R.L. Swift Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli J. Clin. Microbiol. 20 1984 323
9. G.W. Duff, and E. Atkins The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation J. Immunol. Methods 52 1982 323
10. S. Eperon, and T.W. Jungi The use of human monocytoid lines as indicators of endotoxin J. Immunol. Methods 194 1996 121
11. S. Eperon, D. De Groote, G. Werner-Felmayer, and T.W. Jungi Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and limulus amoebocyte lysate assay J. Immunol. Methods 207 1997 135
12. European Union, 1986. EU-Directive 86/609/EEC. Official Journal of the European Union L 358.
13. S. Fennrich, M. Fischer, T. Hartung, P. Lexa, T. Montag-Lessing, H.G. Sonntag, M. Weigandt, and A. Wendel Detection of endotoxins and other pyrogens using human whole blood Dev. Biol. Stand. 101 1999 131
14. T. Harada, A. Misaki, and H. Saito Curdlan: a bacterial gel-forming beta-1,3-glucan Arch. Biochem. Biophys. 124 1968 292
15. T. Hartung, and A. Wendel Detection of pyrogens using human whole blood In Vitro Toxicol. 9 1996 353
16. T. Hartung, I. Aaberge, S. Berthold, G. Carlin, E. Charton, S. Coecke, S. Fennrich, M. Fischer, M. Gommer, M. Halder, K. Haslov, M. Jahnke, T. Montag-Lessing, S. Poole, L. Schechtman, A. Wendel, and G. Werner-Felmayer Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods Altern. Lab. Anim. 29 2001 99
17. Hoffmann, S., Luederitz-Puechel, U., Montag-Lessing, T., Hartung, T. in press. Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling. J. Endotoxin Res.
18. J. Levin, and F.B. Bang A description of cellular coagulation in the limulus Bull. Johns Hopkins Hosp. 115 1964 337
19. C.C. Mascoli, and M.E. Weary Applications and advantages of the limulus amebocyte lysate (LAL) pyrogen test for parenteral injectable products Prog. Clin. Biol. Res. 29 1979 387
20. C.C. Mascoli, and M.E. Weary Limulus amebocyte lysate (LAL) test for detecting pyrogens in parenteral injectable products and medical devices: advantages to manufacturers and regulatory officials J. Parenter. Drug Assoc. 33 1979 81
21. S. Morath, A. Geyer, and T. Hartung Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus J. Exp. Med. 193 2001 393
22. S. Morath, A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations Infect. Immun. 70 2002 938
23. Y. Nakagawa, H. Maeda, and T. Murai Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test Clin. Diagn. Lab. Immunol. 9 2002 588
24. A. Peterbauer, E.R. Werner, and G. Werner-Felmayer Further development of a cell culture model for the detection of bacterial pyrogens ALTEX 16 1999 3
25. A. Peterbauer, S. Eperon, T.W. Jungi, E.R. Werner, and G. Werner-Felmayer Interferon-gamma-primed monocytoid cell lines: optimizing their use for in vitro detection of bacterial pyrogens J. Immunol. Methods 233 2000 67
26. S. Poole, and M.V. Mussett The international standard for endotoxin: evaluation in an international collaborative study J. Biol. Stand. 17 1989 161
27. S. Poole, R. Thorpe, A. Meager, A.R. Hubbard, and A.J. Gearing Detection of pyrogen by cytokine release Lancet 8577 1988 130
28. S. Poole, P. Dawson, and R.E. Gaines Das Second international standard for endotoxin: calibration in an international collaborative study J. Endotoxin Res. 4 1997 221
29. S. Poole, Y. Mistry, C. Ball, R.E. Gaines Das, L.P. Opie, G. Tucker, and M. Patel A rapid 'one-plate' in vitro test for pyrogens J. Immunol. Methods 274 2003 209 220
30. P.F. Roslansky, and T.J. Novitsky Sensitivity of limulus amebocyte lysate (LAL) to LAL-reactive glucans J. Clin. Microbiol. 29 1991 2477
31. W.M.S. Russel, and R.L. Burch The principles of humane experimental technique 1959 Methuen London
32. S. Schindler, A. Bristow, T. Cartmell, T. Hartung, and S. Fennrich Comparison of the reactivity of human and rabbit blood towards pyrogenic stimuli ALTEX 20 2003 59
33. R.P. Schins, B. van Hartingsveldt, and P.J. Borm Ex vivo cytokine release from whole blood. A routine method for health effect screening Exp. Toxicol. Pathol. 48 1996 494
34. I. Spreitzer, M. Fischer, K. Hartzsch, U. Luderitz-Puchel, and T. Montag Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin ALTEX 19 Suppl 1 2002 73
35. Y.S. Taktak, S. Selkirk, A.F. Bristow, A. Carpenter, C. Ball, B. Rafferty, and S. Poole Assay of pyrogens by interleukin-6 release from monocytic cell lines J. Pharm. Pharmacol. 43 1991 578
36. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) Int. J. Cancer 26 1980 171
37. C.W. Twohy, A.P. Duran, and T.E. Munson Endotoxin contamination of parenteral drugs and radiopharmaceuticals as determined by the limulus amebocyte lysate method J. Parenter. Sci. Technol. 38 1984 190
38. A.P. Worth, and M. Balls The principles of validation and the ECVAM validation process Altern. Lab. Anim. 30 Suppl 2 2002 15
39. H.W. Ziegler-Heitbrock, E. Thiel, A. Futterer, V. Herzog, A. Wirtz, and G. Riethmuller Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes Int. J. Cancer 41 1988 456